Evidence map›Paper›PMID 37636034›Full record

ArticleiScience2023

Integrative analysis identifies two molecular and clinical subsets in Luminal B breast cancer.

Huina Wang, Bo Liu, Junqi Long, Jiangyong Yu, Xinchan Ji, Jinmeng Li, Nian Zhu, Xujie Zhuang, Lujia Li, Yuhaoran Chen and 3 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in iScience, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Huina WangSchool of Software Engineering, Faculty of Information Technology, Beijing University of Technology, Beijing 100124, China.
Bo LiuSchool of Mathematical and Computational Sciences, Massey University, Palmerston North 4472, New Zealand.
Junqi LongSchool of Software Engineering, Faculty of Information Technology, Beijing University of Technology, Beijing 100124, China.
Jiangyong YuDepartment of Medical Oncology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing 100730, China.
Xinchan JiSchool of Software Engineering, Faculty of Information Technology, Beijing University of Technology, Beijing 100124, China.
Jinmeng LiSchool of Software Engineering, Faculty of Information Technology, Beijing University of Technology, Beijing 100124, China.
Nian ZhuSchool of Software Engineering, Faculty of Information Technology, Beijing University of Technology, Beijing 100124, China.
Xujie ZhuangSchool of Software Engineering, Faculty of Information Technology, Beijing University of Technology, Beijing 100124, China.
Lujia LiSchool of Software Engineering, Faculty of Information Technology, Beijing University of Technology, Beijing 100124, China.
Yuhaoran ChenSchool of Software Engineering, Faculty of Information Technology, Beijing University of Technology, Beijing 100124, China.
Zhidong LiuDepartment of Thoracic Surgery, Beijing Tuberculosis and Thoracic Tumor Research Institute/Beijing Chest Hospital, Capital Medical University, Beijing 101149, China.
Shu WangBreast Disease Center, Peking University People's Hospital, Peking University, Beijing 100044, China.
Shuangtao ZhaoDepartment of Thoracic Surgery, Beijing Tuberculosis and Thoracic Tumor Research Institute/Beijing Chest Hospital, Capital Medical University, Beijing 101149, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Comprehensive multiplatform analysis of Luminal B breast cancer (LBBC) specimens identifies two molecularly distinct, clinically relevant subtypes: Cluster A associated with cell cycle and metabolic signaling and Cluster B with predominant epithelial mesenchymal transition (EMT) and immune response pathways. Whole-exome sequencing identified significantly mutated genes including

Indexed as

BioinformaticsCancer systems biologyMicroenvironment

Identifiers

PMID37636034
PMCPMC10448479

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.